Ardelyx
Fremont, CA
Ardelyx, Inc. manufactures biotechnological drugs. The Company offers pharmaceuticals to correct mineral metabolism imbalance and metabolic disorders by modulating the function of specific transporters, channels, and receptors located on the epithelia of the gastrointestinal tract. Ardelyx serves patients in the United States.
ardelyx.comCompany Details
Founded
- 2007
Employees
- 395 employees
Raised
- $557,675,328
Headquarters Location
- Fremont, CA
Public
- Yes
Acquired
- No
CEO
Mike Raab
Founders
- Peter SchultzDominique Charmot
Company Collections
These are collections Ardelyx is a part of. Click on the collection name to view similar companies.
Ardelyx's Industries
Ardelyx Headquarters Location
Total Amount Raised: $557,675,328
Ardelyx Funding Rounds
Post Ipo Debt
$20,000,000
Post Ipo Debt Investors
HealthCare Royalty PartnersKyowa Kirin Co.Post Ipo Debt
$27,500,000
Post Ipo Debt Investors
SLR Capital PartnersPost Ipo Equity
$125,000,000
Post Ipo Debt
$50,000,000
Post Ipo Equity
$110,000,000
Post Ipo Equity Investors
NEA - New Enterprise AssociatesQuadrille CapitalEcoR1 CapitalRA Capital ManagementFirst Manhattan Consulting GroupRock Springs CapitalCormorant Asset ManagementPerceptive AdvisorsDeerfield ManagementDafna Capital ManagementPost Ipo Equity
$86,300,000
Post Ipo Equity
$77,771,627
Post Ipo Equity Investors
NEA - New Enterprise AssociatesRA Capital ManagementBroadfin CapitalCormorant Asset ManagementForesite CapitalRock Springs CapitalSabby CapitalIPO
Unknown
Series B
$30,000,000
Series B Investors
AmgenCMEA CapitalNEA - New Enterprise AssociatesDebt Financing
$5,013,694
Series A
$26,090,000
Series A Investors
CMEA Capital
Ardelyx Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ardelyx.